The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2006
Filed:
Jun. 06, 1995
S. Christopher Bauer, New Haven, MO (US);
Mark Allen Abrams, St. Louis, MO (US);
Sarah Ruth Braford-goldberg, St. Louis, MO (US);
Marie Helena Caparon, Chesterfield, MO (US);
Alan Michael Easton, Maryland Heights, MO (US);
Barbara Kure Klein, St. Louis, MO (US);
John Patrick Mckearn, Glencoe, MO (US);
Peter O. Olins, Glencoe, MO (US);
Kumnan Paik, Ballwin, MO (US);
John Warren Thomas, Town & Country, MO (US);
S. Christopher Bauer, New Haven, MO (US);
Mark Allen Abrams, St. Louis, MO (US);
Sarah Ruth Braford-Goldberg, St. Louis, MO (US);
Marie Helena Caparon, Chesterfield, MO (US);
Alan Michael Easton, Maryland Heights, MO (US);
Barbara Kure Klein, St. Louis, MO (US);
John Patrick McKearn, Glencoe, MO (US);
Peter O. Olins, Glencoe, MO (US);
Kumnan Paik, Ballwin, MO (US);
John Warren Thomas, Town & Country, MO (US);
Other;
Abstract
The present invention relates to fusion molecules composed of human interleukin-3 (hIL-3) variant or mutant proteins (muteins) functionally joined to a second colony stimulating factor (CSF), cytokine, lymphokine, interleukin or IL-3 variant. These hIL-3 variants contain amino acid substitutions and may also have amino acid deletions at both the N- and C-termini. The invention also relates to pharmaceutical compositions containing the fusion molecules and methods for using them.